Citations

Showing 10 of 108162 citations.

Neuropsychological decline up to 20 years before incident mild cognitive impairment
Caselli, Richard J. , Langlais, Blake, Dueck, Amylou C. , Chen, Yinghua , Su, Yi , Woodruff, Bryan K. , Reiman, Eric M. , Langlais, Blake T., Locke, Dona E.C. , Dueck, A. C.

Mayo Clinic

Alzheimer's & Dementia | November 28, 2019 | Volume: 16 | Issue: 3 | Pages: 512-523

10.1016/j.jalz.2019.09.085 | PMID 31787561 Get It

Abstract Introduction Some Alzheimer's disease biomarker studies found amyloid changes 20 years or more in advance of expected symptoms, while cognitive changes lagged for more than a decade, but this apparent lag might reflect the sensitivities of the biomarker and cognitive assays used. How far in advance of incident amnestic mild cognitive impairment (MCI) does cognition begin to decline? Methods Longitudinal neuropsychological study of an apolipoprotein E e4 enriched cohort of cognitively normal individuals at entry. Linear mixed models for MCI converters (n = 65) and nonconverters (n = 719) fitted for each neuropsychological measure; annual changes compared between groups before and after linear model intersections (inflection points). Results 34 of 35 cognitive measures and 9 of 18 behavioral measures declined faster post‐inflection in the MCI converters; the earliest cognitive inflection point was nearly 20 years in advance of MCI diagnosis. Discussion The preclinical duration of cognitive and behavioral changes approaches the earliest reported biomarker changes.
Patient Engagement Survey Regarding Future Double-Blinded, Randomized Controlled Trial of Tapering of Chronic Opioid Therapy
James, Jared , Witt, Terrence J. , Lai, Benjamin , Witt, Terrence , Lai, Benjamin

Mayo Clinic

Journal of Primary Care & Community Health | November 28, 2019 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2150132719890231 | PMID 31777325 Get It

Objective: There is a lack of evidence regarding tapering opioid medications in patients with chronic non-cancer pain. The purpose of this survey was to gather perspectives on future research into opioid tapering from utilizers of chronic opioid therapy (COT) or other people affected by chronic noncancer pain. Methods: The survey was distributed in paper form to patients on COT and via an online platform to patients self-enrolled in the chronic pain patient engagement group. The survey included a layman’s description of a possible tapering trial of opioid medications and elicited binary responses regarding willingness to participate and reasoning as well as qualitative freeform responses. Thematic analysis was performed to identify themes in narrative responses. Results: A total of 190 surveys were returned with 72.1% of all respondents answering positively regarding their willingness to participate in a proposed study. The most common reasons for participating in the study included concerns regarding opioid dependence, adding to society’s knowledge of opioid medications, and determining if the respondent would personally receive benefit from opioid medications. Patients recently on COT felt it was important to be able to withdraw from the study and return to usual care at any time (41.8% for recent COT and 15.5% for no recent COT, P < .05). The most common reason for unwillingness to participate was that respondents did not feel they had enough information to feel comfortable participating. The narrative responses showed a group of respondents felt COT was the only answer to their or their loved ones’ chronic pain and that a study would demonstrate the need to continue these medications long-term. There were also stories of side effects and dependence with decreasing effectiveness of opioids for pain control. When prompted to comment on study design, respondents indicated the study should include alternative pain management options. This was accompanied by responses with the assumption that pain will worsen as opioid medications are decreased. Conclusion: Patient concerns regarding opioid medications and discontinuation reflect the lack of evidence available to prescribers. There appears to be patient support for future research into the effects of tapering opioid medications.
Modernizing Storage Conditions for Fresh Osteochondral Allografts by Optimizing Viability at Physiologic Temperatures and Conditions
Denbeigh, Janet M. , Paggi, Carlo Alberto , Resch, Zachary T., Bagheri, Leila, Mara, Kristin C. , Arani, Arvin , Zhang, Chenghao , Saris, Daniël B.F. , Krych, Aaron J. , Wijnen, André J. van , Paggi, Carlo A, Mara, Kristin, Krych, Aaron J , van Wijnen, Andre J , van Wijnen, Andre J , Arani, Arvin , Mara, Kristin C , Hevesi, Mario , Larson, A. Noelle

Mayo Clinic

CARTILAGE | November 28, 2019 | Volume: 13 | Issue: 1_suppl | Pages: 280S-292S

10.1177/1947603519888798 | PMID 31777278 Get It

Objective. Osteochondral allograft (OCA) transplantation has demonstrated good long-term outcomes in treatment of cartilage defects. Viability, a key factor in clinical success, decreases with peri-implantation storage at 4°C during pathogen testing, matching logistics, and transportation. Modern, physiologic storage conditions may improve viability and enhance outcomes. Design. Osteochondral specimens from total knee arthroplasty patients (6 males, 5 females, age 56.4 ± 2.2 years) were stored in media and incubated at normoxia (21% O 2 ) at 22°C or 37°C, and hypoxia (2% O 2 ) at 37°C. Histology, live-dead staining, and quantitative polymerase chain reaction (qPCR) was performed 24 hours after harvest and following 7 days of incubation. Tissue architecture, cell viability, and gene expression were analyzed. Results. No significant viability or gene expression deterioration of cartilage was observed 1-week postincubation at 37°C, with or without hypoxia. Baseline viable cell density (VCD) was 94.0% ± 2.7% at day 1. At day 7, VCD was 95.1% (37°C) with normoxic storage and 92.2% (37°C) with hypoxic storage ( P ≥ 0.27). Day 7 VCD (22°C) incubation was significantly lower than both the baseline and 37°C storage values (65.6%; P < 0.01). COL1A1, COL1A2, and ACAN qPCR expression was unchanged from baseline ( P < 0.05) for all storage conditions at day 7, while CD163 expression, indicative of inflammatory macrophages and monocytes, was significantly lower in the 37°C groups ( P < 0.01). Conclusion. Physiologic storage at 37°C demonstrates improved chondrocyte viability and metabolism, and maintained collagen expression compared with storage at 22°C. These novel findings guide development of a method to optimize short-term fresh OCA storage, which may lead to improved clinical results.
Opportunistic Computed Tomography and Spine Surgery: A Narrative Review
Wanderman, Nathan , Keaveny, Tony M. , Anderson, Paul A. , Freedman, Brett A. , Shirley, Matthew, Freedman, Brett A , Shirley, Matthew

Mayo Clinic

Global Spine Journal | November 28, 2019 | Volume: 10 | Issue: 7 | Pages: 919-928

10.1177/2192568219889362 | PMID 32905730 Get It

Study Design: Narrative review. Objective: This article seeks to provide a narrative review regarding the ability of opportunistic information available from computed tomography (CT) scans to guide decisions in spine surgery related to patient bone quality. Methods: A review of the literature (limited to human and English language) was performed via PubMed and Google Scholar using the search terms; “osteoporosis” AND “opportunistic” AND “computed tomography” AND “spine surgery.” The titles and then abstracts of all identified citations were reviewed for inclusion by 2 of the authors (MS, BAF). Relevant articles were then studied in full text. Results: A review of the literature found 25 articles that were selected for inclusion in this narrative review. These articles were broadly divided into 4 subcategories: (1) opportunistic CT (oCT) and osteoporosis detection, (2) oCT data and the quality of screw fixation, (3) utilization of Hounsfield units to assess clinical and/or radiographic outcomes following spine fusion, and (4) virtual stress testing in spine surgery. Conclusion: The literature on oCT, as well as associated virtual stress-testing techniques, demonstrate the potential to enhance spine surgery outcomes by preoperatively identifying at-risk patients in need of bone health optimization and informing best techniques for performing spinal fusion surgery on patients with diminished bone quality. While our narrative summary of the limited literature to date suggests a promising future for oCT data, significant additional research and/or radiographic workflow standardization is needed to validate these methods for clinical use.
Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline
Wallach, Asya I. , Waltz, Michael , Casper, T. Charles , Aaen, Gregory , Belman, Anita , Chitnis, Tanuja , Gorman, Mark , Graves, Jennifer , Harris, Yolanda, Lotze, Timothy , Mar, Soe , Moodley, Manikum , Ness, Jayne , Rodriguez, Moses , Rose, John , Schreiner, Teri , Tillema, Jan‐Mendelt , Charvet, Leigh , Krupp, Lauren , Chitnis, Tanuja , Graves, Jennifer , Krupp, Lauren , Rodriguez, Moses , Charvet, Leigh E , Benson, Leslie, Rensel, Mary R. , Schreiner, Teri , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca

Mayo Clinic

Multiple Sclerosis Journal | November 28, 2019 | Volume: 26 | Issue: 14 | Pages: 1938-1947

10.1177/1352458519891984 | PMID 31775571 Get It

Background: Cognitive impairment occurs in approximately one-third of pediatric-onset multiple sclerosis (POMS) patients. The Symbol Digit Modalities Test (SDMT), a widely used cognitive screen in adults, has yet to be incorporated early into the standard care of POMS. Objective: To screen for cognitive impairment early in the course of POMS and analyze predictive factors. Methods: Of the 955 POMS or clinically isolated syndrome (CIS) patients prospectively assessed from March 2014 to July 2018, 500 POMS and 116 CIS patients met inclusion criteria (disease onset before the age of 18, one or more SDMTs, and 8 years or older at the time of testing). Those with relapse were analyzed separately from those who were relapse-free. Results: At initial assessment, the mean (interquartile range (IQR)) age at symptom onset was 13.5 years (12.0, 15.9) and the mean (±SD) disease duration was 3.0 ± 2.9 years. Impaired processing speed occurred in 23.4% of POMS and in 16.4% of CIS. On serial testing ( n = 383, mean follow-up: 1.8 years), 14.1% had clinically meaningful decline predicted by older age of multiple sclerosis (MS) onset and male gender. Disease relapse or steroid use led to transient worsening on the SDMT. Conclusion: Early in the disease, some POMS and CIS patients are at risk for cognitive impairment and subsequent decline.
Coverage profile correction of shallow-depth circulating cell-free DNA sequencing via multidistance learning
Sosa, Carlos P., Kocher, Jean-Pierre, Rowsey, Ross, Larson, Nicholas B. , Larson, Melissa C. , Na, Jie, Wang, Chen

Mayo Clinic

Biocomputing 2020 | November 28, 2019 | Volume: No volume available | Issue: No issue available | Pages: 599-610

10.1142/9789811215636_0053 Get It

Clinical Outcomes Following Tongue Type Calcaneus Fractures
Burnett, Zachary , Barzee, Brigham M. , Hymes, Robert A. , Cannada, Lisa K.

Mayo Clinic

Techniques in Orthopaedics | November 28, 2019 | Volume: 36 | Issue: 2 | Pages: 166-170

10.1097/bto.0000000000000425 Get It

Background: Calcaneus fractures have serious potential complications. Tongue type calcaneus fractures, in particular, are at risk for secondary soft tissue breakdown due in part to the tension placed on the soft tissue by the forces of the Achilles tendon on the superior fragment of the posterior calcaneal tuberosity. The current literature is limited regarding outcomes in pure tongue type calcaneus fractures. The purpose of this study is to report injury details, treatment, and complications in this group of fractures. Methods: The study is a retrospective study of patients between 2007 and 2015 with tongue type calcaneus fractures. Demographic data and comorbidities were collected for each patient. Clinical data including details of the injury, time to surgery, length of hospital stay, wound complications, additional surgical procedures, and follow-up data were evaluated. Results: There were 25 patients with 26 fractures included in this study, including 7 open fractures. Wound complications occurred in 7 (27%) patients, and fixation failure occurred in 4 (21%) patients. Patients with open fractures reached full healing in less time (2.8±0.4 mo) compared with patients with closed fractures (4±1.3 mo). The difference in time to full healing was not statistically significant (P>0.05) when comparing smokers and nonsmokers. Conclusions: The literature is limited regarding outcomes of pure tongue type calcaneus fractures. We found these fractures had similar or even higher rates of wound complications compared with other studies investigating intra-articular calcaneus fractures. This is one of the first studies to report on the complication rates associated specifically with these fractures. Level of Evidence: Level IV.
Quantifying Tertiary Referral Center Bias in Vestibular Schwannoma Research
Saba, Elias S. , Marinelli, John P. , Lohse, Christine M. , Link, Michael J. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | November 28, 2019 | Volume: 41 | Issue: 2 | Pages: 258-264

10.1097/mao.0000000000002496 | PMID 31789811 Get It

Objective: The majority of research influencing our understanding of vestibular schwannoma (VS) comes from large tertiary referral centers, and as a consequence, is inherently prone to referral bias. The objective of the current study was to characterize tertiary referral center bias in VS research. Study design: Single-institution retrospective clinical, audiometric, and radiologic review. Setting: One tertiary referral center. Patients: One hundred twenty-three patients with sporadic VS treated at our institution, consisting of a local cohort of all 41 VS patients residing in the same US county as our medical center and a referral cohort of 82 patients from outside counties matched 2:1 based on age, sex, and year of diagnosis. Intervention: Surgical resection, stereotactic radiosurgery (SRS), observation. Main outcome measures: Clinical manifestations, audiometric and radiologic findings, elected treatment modality. Results: Local patients had significantly longer follow-up after initial presentation compared to referral patients (median 4.0 vs 2.2 yr; p = 0.007). Referral patients were significantly less likely to have an incidental VS diagnosis (1% vs. 29%; p < 0.001) and presented with worse symptomatology such as hearing loss (80% vs. 54%; p = 0.002), dizziness (72% vs. 44%; p = 0.002), headache (29% vs. 15%; p = 0.075), and other cranial nerve dysfunction (11% vs. 0%; p = 0.029). Audiometrically, referral patients had significantly poorer word recognition scores at presentation (median 70% vs. 90%; p = 0.043). Local patients were more likely to have tumors confined to the IAC compared with referral patients, and had significantly smaller tumors when restricted to this region (median 4.0 vs 6.5 mm; p = 0.005). Referral patients were significantly more likely to undergo definitive management with either radiosurgery or microsurgery following primary evaluation compared to local patients (48% vs. 24%; p = 0.013). Conclusion: These data suggest that the majority of existing literature surrounding VS likely suffers from referral bias, whereby disease characteristics and management decisions are distinct from that of the general VS patient population.
Atrial Fibrillation: Thinking Beyond Thromboembolism
Reddy, Yogesh N.V. , Nishimura, Rick , Borlaug, Barry A.

Mayo Clinic

European Journal of Heart Failure | November 27, 2019 | Volume: 21 | Issue: 12 | Pages: 1580-1583

10.1002/ejhf.1683 | PMID 31777151 Get It

Early Cutoff Criteria for Strong Performance on the Test of Memory Malingering
Polsinelli, Angelina J. , Cerhan, Jane H.

Mayo Clinic

Archives of Clinical Neuropsychology | November 27, 2019 | Volume: 35 | Issue: 4 | Pages: 429-433

10.1093/arclin/acz079 | PMID 31867600 Get It

Abstract Objective The Test of Memory Malingering (TOMM) is widely used to assess performance validity. To improve efficiency, we investigated whether abbreviated administration (i.e., only the first 25 items of Trial 1 [T1]) is possible when effort is very strong (≥49/50 on T1 or T2). Method We collected TOMM scores of 501 consecutive adult patients ranging in cognitive status who underwent standard neuropsychological evaluation at Mayo Clinic, Rochester, MN. Results Receiver Operating Characteristic (ROC) analysis showed excellent area under the curve (AUC) (0.94; CI95% [0.92, 0.97]) and a cutoff of 25/25 had 100% specificity for identifying strong performance. Of the 224 patients who obtained a perfect score on the first 25 items, 197 (88%) obtained ≥49 on T1 and the remaining patients (n = 27) obtained ≥49 on T2. Conclusion A perfect score on the first 25 items of the TOMM predicted overall strong performance 100% of the time, supporting abbreviated administration in select cases in a general outpatient clinical setting.